Search
Products
Community
Markets
News
Brokers
More
EN
Get started
Iovance Biotherapeutics, Inc.
Long
Sep 15, 2017
IOVA - good long term hold
1
Grab this chart
Grab this chart
IOVA has FDA fast track approval for new cancer immune therapy drug
rollingw
Follow
Trend Analysis
rollingw
Follow
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the
Terms of Use
.